Month: November 2021

Regulatory News: MedinCell (Paris:MEDCL): Developed in collaboration with Teva Pharmaceuticals, mdc-IRM, a risperidone extended-release injectable suspension for the treatment of patients with …

Psychosocial and psychological interventions are effective for relapse prevention in schizophrenia, according to a review published online Oct. 12 in The Lancet Psychiatry . Irene Bighelli, Ph.D., …

The global Schizophrenia Treatment Market is expected to stimulate at a good rate In Upcoming Years Virtual consultations are amongst the ongoing trends They mitigate the spreading of contagious …

Investigators report the results of a post hoc analysis of a trial investigating the effectiveness of HP-3070 on hostility in patients with schizophrenia.